Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA dimerization defect in a Rous sarcoma virus matrix mutant.

L J Parent1, T M Cairns, J A Albert

  • 1Department of Medicine, The Pennsylvania State University College of Medicine, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

Journal of Virology
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunologic aspects of renal diseases.

JAMA·1992
Same author

Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.

Neurosurgery·1992
Same author

Ontogeny of T lymphocyte function in the neonate.

American journal of reproductive immunology (New York, N.Y. : 1989)·1992
Same author

Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury.

Journal of the American Society of Nephrology : JASN·1992
Same author

Positron emission tomography for tumour assessment.

NMR in biomedicine·1992
Same author

Radiosurgery: a new application?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992

A Rous sarcoma virus (RSV) matrix (MA) mutant, Myr1E, shows a replication defect due to impaired genomic RNA dimerization, not myristoylation. Restoring RNA dimerization rescues infectivity, suggesting MA’s role in RNA packaging.

Area of Science:

  • Retroviral assembly and replication
  • Molecular virology
  • Protein-domain interactions

Background:

  • The retrovirus matrix (MA) protein is crucial for membrane targeting during virus assembly.
  • MA mutants in various retroviruses exhibit defects in infectivity despite normal particle release.
  • The function of MA in genomic RNA packaging and dimerization remains incompletely understood.

Purpose of the Study:

  • To investigate the function of the Rous sarcoma virus (RSV) MA protein in viral particle assembly and infectivity.
  • To characterize a novel RSV MA mutant, Myr1E, with an N-terminal Src oncoprotein domain.
  • To determine the role of MA in genomic RNA dimerization and its impact on viral replication.

Main Methods:

  • Construction and characterization of the RSV MA mutant Myr1E.

Related Experiment Videos

  • Biochemical analysis of viral particle composition, including Gag cleavage products, Env glycoproteins, and reverse transcriptase activity.
  • Analysis of genomic RNA incorporation, dimerization status, and template activity using Northern blots and reverse transcriptase assays.
  • Infectivity assays in avian cells.

    • Main Results:

    • The Myr1E mutant, despite normal particle release and Gag processing, is non-infectious.
    • Myristoylation of the N-terminal extension is not the cause of the replication defect.
    • Myr1E particles exhibit defective genomic RNA dimerization, with RNA appearing monomeric.
    • Genomic RNA from Myr1E particles can serve as a template for reverse transcription in vitro but not in vivo after infection.

    Conclusions:

    • The replication defect in Myr1E is linked to impaired genomic RNA dimerization, not myristoylation.
    • The study suggests a novel role for the MA protein in facilitating or stabilizing genomic RNA dimerization.
    • Interference with RNA dimerization by the mutant MA protein may explain the observed block in viral replication.